Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Finished Goods: 2010-2025

Historic Finished Goods for BIO-TECHNE (TECH) over the last 14 years, with Jun 2025 value amounting to $106.2 million.

  • BIO-TECHNE's Finished Goods rose 5.58% to $114.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.9 million, marking a year-over-year increase of 5.58%. This contributed to the annual value of $106.2 million for FY2025, which is 0.11% up from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Finished Goods is $106.2 million, which was up 0.11% from $106.1 million recorded in FY2024.
  • BIO-TECHNE's 5-year Finished Goods high stood at $106.2 million for FY2025, and its period low was $66.9 million during FY2022.
  • Over the past 3 years, BIO-TECHNE's median Finished Goods value was $106.1 million (recorded in 2024), while the average stood at $101.6 million.
  • Per our database at Business Quant, BIO-TECHNE's Finished Goods declined by 0.25% in 2022 and then soared by 38.14% in 2023.
  • BIO-TECHNE's Finished Goods (Yearly) stood at $67.1 million in 2021, then declined by 0.25% to $66.9 million in 2022, then spiked by 38.14% to $92.5 million in 2023, then increased by 14.70% to $106.1 million in 2024, then climbed by 0.11% to $106.2 million in 2025.